Absence of CD5 dramatically reduces progression of pulmonary inflammatory lesions in SHP-1 protein-tyrosine phosphatase-deficient 'viable motheaten' mice

Journal of Autoimmunity

Volumn 18, Issue 2, 2002, Pages 105-117

  Joliat, Melissa J ^a   Lang, Pamela A ^a   Lyons, Bonnie L ^a   Burzenski, Lisa ^a   Lynes, Michael A ^b   Yi, Taolin ^c   Sundberg, John P ^a   Shultz, Leonard D ^a  

^a JACKSON LABORATORY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cell surface molecules; Inflammation; Kinases phosphatases; Monocytes macrophages; Mouse

Indexed keywords

AUTOANTIBODY; CD11B ANTIGEN; CD5 ANTIGEN; IMMUNOGLOBULIN M; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; FLOW CYTOMETRY; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY DISEASE; LIFESPAN; LONGEVITY; LUNG INJURY; MOUSE; MOUSE STRAIN; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SPECIES COMPARISON; SPLEEN CELL; SRC HOMOLOGY DOMAIN; T LYMPHOCYTE;

EID: 0036525422     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2001.0570     Document Type: Article

References (85)

1. Shultz L.D., Coman D.R., Bailey C.L., Beamer W.G., Sidman C.L. Viable motheaten, a new allele at the motheaten locus. I. Pathology. Am. J. Path. 116:1984;179-192.
2. Shultz L.D., Green M.C. Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins. J. Immunol. 116:1976;936-943.
3. Sidman C.L., Shultz L.D., Unanue E.R. The mouse mutant motheaten. II. Functional studies of the immune system. J. Immunol. 121:1978;2399-2404.
4. Davidson W.F., Morse H.C.D., Sharrow S.O., Chused T.M. Phenotypic and functional effects of the motheaten gene on murine B and T lymphocytes. J. Immunol. 122:1979;884-891.
5. Yi T., Gilbert D.J., Jenkins N.A., Copeland N.G., Ihle J.N. Assignment of a novel protein tyrosine phosphatase gene (Hcph) to mouse chromosome 6. Genomics. 14:1992;793-795.
6. Yi T.L., Cleveland J.L., Ihle J.N. Protein tyrosine phosphatase containing SH2 domains: characterization, preferential expression in hematopoietic cells, and localization to human chromosome 12p12-p13. Mol. Cell Biol. 12:1992;836-846.
7. Jiao H., Yang W., Berrada K., Tabrizi M., Shultz L., Yi T. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: detection of potential HCP substrates in GM-CSF signal transduction. Exp. Hematol. 25:1997;592-600.
8. Tapley P., Shevde N.K., Schweitzer P.A., Gallina M., Christianson S.W., Lin I.L., Stein R.B., Shultz L.D., Rosen J., Lamb P. Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten mice. Exp. Hematol. 25:1997;122-131.
9. Zhang J., Somani A.K., Siminovitch K.A. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling. Semin. Immunol. 12:2000;361-378.
10. Shultz L.D., Schweitzer P.A., Rajan T.V., Yi T., Ihle J.N., Matthews R.J., Thomas M.L., Beier D.R. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell. 73:1993;1445-1454.
11. Nakayama K., Takahashi K., Shultz L.D., Miyakawa K., Tomita K. Abnormal development and differentiation of macrophages and dendritic cells in viable motheaten mutant mice deficient in haematopoietic cell phosphatase [published erratum appears in Int J Exp Pathol 1997 Oct;78(5):364]. Int. J. Exp. Path. 78:1997;245-257.
12. Van Zant G., Shultz L. Hematologic abnormalities of the immunodeficient mouse mutant, viable motheaten (mev). Exp. Hematol. 17:1989;81-87.
13. Sidman C.L., Marshall J.D., Allen R.D. Murine viable motheaten mutation reveals a gene critical to the development of both B and T lymphocytes. Proc. Natl Acad. Sci. USA. 86:1989;6279-6282.
14. Komschlies K.L., Greiner D.L., Shultz L., Goldschneider I. Defective lymphopoiesis in the bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. III. Normal mouse bone marrow cells enable mev/mev prothymocytes to generate thymocytes after intravenous transfer. J. Exp. Med. 166:1987;1162-1167.
15. Greiner D.L., Goldschneider I., Komschlies K.L., Medlock E.S., Bollum F.J., Schultz L. Defective lymphopoiesis in bone marrow of motheaten (me/me) and viable motheaten (mev/mev) mutant mice. I. Analysis of development of prothymocytes, early B lineage cells, and terminal deoxynucleotidyl transferase-positive cells. J. Exp. Med. 164:1986;1129-1144.
16. Sherr D.H., Dorf M.E., Gibson M., Sidman C.L. Ly-1 B helper cells in autoimmune viable motheaten mice. J. Immunol. 139:1987;1811-1817.
17. Azzam H.S., Grinberg A., Lui K., Shen H., Shores E.W., Love P.E. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188:1998;2301-2311.
18. Davies A.A., Ley S.C., Crumpton M.J. CD5 is phosphorylated on tyrosine after stimulation of the T-cell antigen receptor complex. Proc. Natl Acad. Sci. USA. 89:1992;6368-6372.
19. Tarakhovsky A., Kanner S.B., Hombach J., Ledbetter J.A., Müller W., Killeen N., Rajewsky K. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science. 269:1995;535-537.
20. Pena-Rossi C., Zuckerman L.A., Strong J., Kwan J., Ferris W., Chan S., Tarakhovsky A., Beyers A.D., Killeen N. Negative regulation of CD4 lineage development and responses by CD5. J. Immunol. 163:1999;6494-6501.
21. Chan S., Waltzinger C., Tarakhovsky A., Benoist C., Mathis D. An influence of CD5 on the selection of CD4-lineage T cells. Eur. J. Immunol. 29:1999;2916-2922.
22. Perez-Villar J.J., Whitney G.S., Bowen M.A., Hewgill D.H., Aruffo A.A., Kanner S.B. CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol. Cell. Biol. 19:1999;2903-2912.
23. Lankester A.C., van Schijndel G.M., Cordell J.L., van Noesel C.J., van Lier R.A. CD5 is associated with the human B cell antigen receptor complex. Eur. J. Immunol. 24:1994;812-816.
24. Tarakhovsky A., Müller W., Rajewsky K. Lymphocyte populations and immune responses in CD5-deficient mice. Eur. J. Immunol. 24:1994;1678-1684.
25. Hayakawa K., Hardy R.R., Parks D.R., Herzenberg L.A. The 'Ly-1 B' cell subpopulation in normal immunodefective, and autoimmune mice. J. Exp. Med. 157:1983;202-218.
26. Hayakawa K., Hardy R.R., Honda M., Herzenberg L.A., Steinberg A.D. Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc. Natl Acad. Sci. USA. 81:1984;2494-2498.
27. Pers J., Jamin C., Predine-Hug F., Lydyard P., Youinou P. The role of CD5-expressing B cells in health and disease (Review). Int. J. Mol. Med. 3:1999;239-245.
28. Sidman C.L., Shultz L.D., Hardy R.R., Hayakawa K., Herzenberg L.A. Production of immunoglobulin isotypes by Ly-1+ B cells in viable motheaten and normal mice. Science. 232:1986;1423-1425.
29. Pani G., Siminovitch K.A., Paige C.J. The motheaten mutation rescues B cell signaling and development in CD45-deficient mice. J. Exp. Med. 186:1997;581-588.
30. Fleming T.J., Fleming M.L., Malek T.R. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151:1993;2399-2408.
31. Springer T., Galfre G., Secher D.S., Milstein C. Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur. J. Immunol. 9:1979;301-306.
32. Waldschmidt T.J., Conrad D.H., Lynch R.G. The expression of B cell surface receptors. I. The ontogeny and distribution of the murine B cell IgE Fc receptor. J. Immunol. 140:1988;2148-2154.
33. Rao M., Lee W.T., Conrad D.H. Characterization of a monoclonal antibody directed against the murine B lymphocyte receptor for IgE. J. Immunol. 138:1987;1845-1851.
34. Hardy R., Hayakawa K. Generation of Ly-1 B cells from developmentally distinct precursors. Enrichment by stromal-cell culture or cell sorting. Ann. NY Acad. Sci. 651:1992;99-111.
35. Hardy R.R., Carmack C.E., Shinton S.A., Kemp J.D., Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1991;1213-1225.
36. Gulley M.L., Ogata L.C., Thorson J.A., Dailey M.O., Kemp J.D. Identification of a murine pan-T cell antigen which is also expressed during the terminal phases of B cell differentiation. J. Immunol. 140:1988;3751-3757.
37. Sato S., Ono N., Steeber D.A., Pisetsky D.S., Tedder T.F. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity. J. Immunol. 157:1996;4371-4378.
38. Tedder T.F., Zhou L.J., Engel P. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol. Today. 15:1994;437-442.
39. Krop I., de Fougerolles A.R., Hardy R.R., Allison M., Schlissel M.S., Fearon D.T. Self-renewal of B-1 lymphocytes is dependent on CD19. Eur. J. Immunol. 26:1996;238-242.
40. Leo O., Foo M., Sachs D.H., Samelson L.E., Bluestone J.A. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl Acad. Sci. USA. 84:1987;1374-1378.
41. Ledbetter J.A., Rouse R.V., Micklem H.S., Herzenberg L.A. T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J. Exp. Med. 152:1980;280-295.
42. Ledbetter J.A., Herzenberg L.A. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:1979;63-90.
43. Coffman R.L. Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol. Rev. 69:1982;5-23.
44. Springer T. Cell-surface differentiation in the mouse. 1980;Plenum Press, New York.
45. Bhattacharya A., Dorf M.E., Springer T.A. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J. Immunol. 127:1981;2488-2495.
46. Ikuta K., Kina T., MacNeil I., Uchida N., Peault B., Chien Y.H., Weissman I.L. A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell. 62:1990;863-874.
47. Stall A.M., Adams S., Herzenberg L.A., Kantor A.B. Characteristics and development of the murine B-1b (Ly-1 B sister) cell population. Ann. NY Acad. Sci. 651:1992;33-43.
48. Stall A.M., Wells S.M., Lam K.P. B-1 cells: unique origins and functions. Sem. Immunol. 8:1996;45-59.
49. Amoura Z., Chabre H., Koutouzov S., Lotton C., Cabrespines A., Bach J.F., Jacob L. Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum. 37:1994;1684-1688.
50. Zouali M., Stollar B.D. A rapid ELISA for measurement of antibodies to nucleic acid antigens using UV-treated polystyrene microplates. J. Immunol. Methods. 90:1986;105-110.
51. Yang W., Mckenna S.D., Jiao H., Tabrizi M., Lynes M. A., Shultz L.D., Yi T. SHP-1 deficiency in B-lineage cells is associated with heightened lyn protein expression and increased lyn kinase activity. Exp. Hematol. 26:1998;1126-1132.
52. Yang W., Tabrizi M., Berrada K., Yi T. SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses. Blood. 91:1998;3746-3755.
53. Murray A.B., Luz A. Acidophilic macrophage pneumonia in laboratory mice. Vet. Pathol. 27:1990;274-281.
54. Ward J.M. Pulmonary pathology of the motheaten mouse. Vet. Pathol. 15:1978;170-178.
55. Pani G., Kozlowski M., Cambier J. C., Mills G.B., Siminovitch K.A. Identification of the tyrosine phosphatase PTP1C as a B cell antigen receptor-associated protein involved in the regulation of B cell signaling [see comments]. J. Exp. Med. 181:1995;2077-2084.
56. Takahashi K., Miyakawa K., Wynn A. A., Nakayama K.I., Myint Y.Y., Naito M., Shultz L.D., Tominaga A., Takatsu K. Effects of granulocyte/macrophage colony-stimulating factor on the development and differentiation of CD5-positive macrophages and their potential derivation from a CD5-positive B-cell lineage in mice. Am. J. Path. 152:1998;445-456.
57. Yu C.C., Tsui H.W., Ngan B.Y., Shulman M.J., Wu G.E., Tsui F.W. B and T cells are not required for the viable motheaten phenotype. J. Exp. Med. 183:1996;371-380.
58. Katoh S., Tominaga A., Migita M., Kudo A., Takatsu K. Conversion of normal Ly-1-positive B-lineage cells into Ly-1-positive macrophages in long-term bone marrow cultures. Dev. Immunol. 1:1990;113-125.
59. Davidson W.F., Pierce J.H., Holmes K.L. Evidence for a developmental relationship between CD5+ B-lineage cells and macrophages. Ann. NY Acad. Sci. 651:1992;112-129.
60. Cumano A., Paige C.J., Iscove N.N., Brady G. Bipotential precursors of B cells and macrophages in murine fetal liver. Nature. 356:1992;612-615.
61. Borrello M.A., Phipps R.P. The B/macrophage cell: an elusive link between CD5+ B lymphocytes and macrophages [see comments]. Immunol. Today. 17:1996;471-475.
62. Graf B.A., Nazarenko D.A., Borrello M.A., Roberts L.J., Morrow J.D., Palis J., Phipps R.P. Biphenotypic B/macrophage cells express COX-1 and up-regulate COX-2 expression and prostaglandin E(2) production in response to pro-inflammatory signals. Eur. J. Immunol. 29:1999;3793-3803.
63. Martin M., Strasser A., Baumgarth N., Cicuttini F.M., Welch K., Salvaris E., Boyd A.W. A novel cellular model (SPGM 1) of switching between the pre-B cell and myelomonocytic lineages. J. Immunol. 150:1993;4395-4406.
64. Borrello M.A., Phipps R.P. Fibroblast-secreted macrophage colony-stimulating factor is responsible for generation of biphenotypic B/macrophage cells from a subset of mouse B lymphocytes. J. Immunol. 163:1999;3605-3611.
65. Tanaka T., Wu G.E., Paige C.J. Characterization of the B cell-macrophage lineage transition in 70Z/3 cells. Eur. J. Immunol. 24:1994;1544-1548.
66. Hara H., Sam M., Maki R.A., Wu G.E., Paige C.J. Characterization of a 70Z/3 pre-B cell derived macrophage clone. Differential expression of Hox family genes. Int. Immunol. 2:1990;691-696.
67. Hanecak R., Zovich D.C., Pattengale P.K., Fan H. Differentiation in vitro of a leukemia virus-induced B-cell lymphoma into macrophages. Mol. Cell Biol. 9:1989;2264-2268.
68. Boyd A.W., Schrader J.W. Derivation of macrophage-like lines from the pre-B lymphoma ABLS 8.1 using 5-azacytidine. Nature. 297:1982;691-693.
69. Luo W., Van de Velde H., von Hoegen I., Parnes J.R., Thielemans K. Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72). J. Immunol. 148:1992;1630-1634.
70. Van de Velde H., von Hoegen I., Luo W., Parnes J.R., Thielemans K. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5 [see comments]. Nature. 351:1991;662-665.
71. Biancone L., Bowen M.A., Lim A., Aruffo A., Andres G., Stamenkovic I. Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes. J. Exp. Med. 184:1996;811-819.
72. Bikah G., Lynd F.M., Aruffo A.A., Ledbetter J.A., Bondada S. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5. Inter. Immunol. 10:1998;1185-1196.
73. Pospisil R., Fitts M.G., Mage R.G. CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences. J. Exp. Med. 184:1996;1279-1284.
74. Agostini C., Trentin L., Perin A., Facco M., Siviero M., Piazza F., Basso U., Adami F., Zambello R., Semenzato G. Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process. Am. J. Physiol. 277:1999;L240-L250.
75. Calvo J., Places L., Padilla O., Vila J.M., Vives J., Bowen M.A., Lozano F. Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand. Eur. J. Immunol. 29:1999;2119-2129.
76. Aruffo A., Melnick M.B., Linsley P.S., Seed B. The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins. J. Exp. Med. 174:1991;949-952.
77. Aruffo A., Bowen M.A., Patel D.D., Haynes B.F., Starling G.C., Gebe J.A., Bajorath J. CD6-ligand interactions: a paradigm for SRCR domain function? Immunol. Today. 18:1997;498-504.
78. Bowen M.A., Aruffo A. Adhesion molecules, their receptors, and their regulation: analysis of CD6-activated leukocyte cell adhesion molecule (ALCAM/CD166) interactions. Transplant Proc. 31:1999;795-796.
79. Klingmuller U., Lorenz U., Cantley L.C., Neel B.G., Lodish H.F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:1995;729-738.
80. Bikah G., Carey J., Ciallella J.R., Tarakhovsky A., Bondada S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science. 274:1996;1906-1909.
81. Imboden J.B., June C.H., McCutcheon M.A., Ledbetter J.A. Stimulation of CD5 enhances signal transduction by the T cell antigen receptor. J. Clin. Invest. 85:1990;130-134.
82. Ceuppens J.L., Baroja M.L. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3. J. Immunol. 137:1986;1816-1821.
83. Verwilghen J., Vandesande R., Vandenberghe P., Ceuppens J.L. Crosslinking of the CD5 antigen on human T cells induces functional IL2 receptors. Cell Immunol. 131:1990;109-119.
84. Simarro M., Calvo J., Vilà J.M., Places L., Padilla O., Alberola-Ila J., Vives J., Lozano F. Signaling through CD5 involves acidic sphingomyelinase, protein kinase C-zeta, mitogen-activated protein kinase kinase, and c-Jun NH2-terminal kinase. J. Immunol. 162:1999;5149-5155.
85. O'Keefe T.L., Williams G.T., Davies S.L., Neuberger M.S. Mice carrying a CD20 gene disruption. Immunogenetics. 48:1998;125-132.